Absorbable Microparticulate Cation Exchanger for Immunotherapeutic Delivery

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 69, Issue 2, 2004, Pages 173-182

  Shalaby, Waleed S W ^a   Yeh, Heidi ^b   Woo, Edward ^b   Corbett, Joel T ^c   Gray, Heidi ^b   June, Carl H ^d   Shalaby, Shalaby W ^c  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c Poly Med Inc   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Absorbable polymers; Cation exchanger; Immunotherapy; Microparticulate; Protein adsorption

Indexed keywords

ABSORPTION; CELLS; CYTOLOGY; ION EXCHANGERS; PROTEINS; SCANNING ELECTRON MICROSCOPY; SYNTHESIS (CHEMICAL);

IMMUNOTHERAPY; MICROPARTICULATE CATION EXCHANGERS;

BIOMATERIALS;

CD28 ANTIGEN; GAMMA INTERFERON; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; POLYGLYCOLIC ACID; POLYLYSINE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CATION EXCHANGE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MOUSE; NONHUMAN; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; T LYMPHOCYTE ACTIVATION; X RAY PHOTOELECTRON SPECTROSCOPY;

EID: 2442509783     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.20040     Document Type: Article

References (20)

1. Minton AP. Effects of excluded surface area and adsorbate clustering on surface adsorption of proteins I. Equilibrium models. Biophys Chem 2000;86:239-247.
2. Schneider HM, Frantz P, Granick S. The bimodal energy landscape when polymers adsorb. Langmuir 1996;12:994-996.
3. Minton AP. Adsorption of globular proteins on locally planar surfaces. II. Models for the effect of multiple adsorbate conformations on adsorption equilibria and kinetics. Biophys J 1999; 76:176-187.
4. Mocellin S, Rossi CR, Lise M, Marincola FM. Adjuvant immunotherapy for solid tumors: From promise to clinical application. Cancer Immunol Immunother 2002;51:83-95.
5. Rook AH, Junkins-Hopkins JM, McGinnis KS, Wysocka M, Richardson SK, Budgin JB, Everitts S, Vittorio CC. Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma. Adv Dermatol 2002;18:29-43.
6. Sadelain M, Riviere I, Brentjens R. Targeting tumours with genetically enhanced T lymphocytes. Natl Rev Cancer 2003;3: 35-45.
7. Helguera G, Morrison SL, Penichet ML. Antibody-cytokine fusion proteins: Harnessing the combined power of cytokines and antibodies for cancer therapy. Clin Immunol 2002;105:233-246.
8. Lemoli RM, Curti A, Fogli M, Ferri E, Baccarani M. The therapeutic role of dendritic cells in cancer immunotherapy. Haematologica 2002;87:62-66.
9. Armstrong TD, Jaffee EM. Cytokine modified tumor vaccines. Surg Oncol Clin N Am 2002;11:681-696.
10. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Natl Rev Cancer 2002;2:850-861.
11. Shalaby SW. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof. United States Patent No. 5,714,159; February 3, 1998.
12. Shalaby SW. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof. United States Patent No. 5,612,052; March 18, 1997.
13. Abe R, Vandenberghe P, Craighead N, Smoot DS, Lee KP, June CH. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation. J Immunol 1995; 154:985-997.
14. Shibuya TY, Wei WZ, Zormeier M, Ensley J, Sakr W, Mathog RH, Meleca RJ, Yoo G, June CH, Levine B, Lum. LG. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1999;125: 1229-1234.
15. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 1987;7:4472-4481.
16. Garlie NK, LeFever AV, Siebenlist RE, Levine BL, June CH, Lum LG. T cells coactivated with immobilized anti-CD3 and anti-CD28 as potential immunotherapy for cancer. J Immunother 1999;22:336-345.
17. LaSurface AES/XPS database of energy and spectra. Web site: http://www.lasurface.com.
18. Pantazaki A, Baron MH, Revault M, Vidal-Madjar C. Characterization of human serum albumin adsorbed on a porous anion-exchange support. J Colloid Interface Sci 1998;207:324-331.
19. Hurwitz AA, Yu TF, Leach DR, Allison JP. CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma. Proc Natl Acad Sci 1998;95:10067-10071.
20. Van Elsas A, Hurwitz AA, Allison JP. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 1999;190: 355-366.